Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.

Two patients with the Wiskott-Aldrich syndrome had complete donor lymphoid and hematopoietic engraftment after successful allogeneic bone-marrow transplantation. One patient had had only a temporary donor T-lymphocyte graft after a previous transplantation, for which he had been prepared with cytarabine and cyclophosphamide; the patient's own T lymphocytes returned six months later. A repeat transplant, for which the patient was prepared with anti-human thymocyte serum, total-body irradiation and procarbazine, resulted in complete donor engraftment. The second patient underwent a successful transplantation after similar preparation, except that procarbazine was omitted. At 11 and five months after transplantation both had normal hematopoiesis and no evidence of graft-versus-host disease. This treatment of the Wiskott-Aldrich syndrome may be a model for the correction of other genetically determined immune and hematologic bone-marrow disorders.

[1]  P. Neiman,et al.  A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. , 1977, The Journal of infectious diseases.

[2]  R. Storb,et al.  HEMOPOIETIC GRAFTS BETWEEN DLA‐IDENTICAL CANINE LITTERMATES FOLLOWING DIMETHYL MYLERAN: EVIDENCE FOR RESISTANCE TO GRAFTS NOT ASSOCIATED WITH DLA AND ABROGATED BY ANTITHYMOCYTE SERUM , 1977, Transplantation.

[3]  Z. Fuks,et al.  Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts , 1977, The Journal of experimental medicine.

[4]  P. Neiman,et al.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.

[5]  T. Stossel,et al.  Bone marrow transplantation for an infant with neutrophil dysfunction. , 1977, Experimental hematology.

[6]  R. Parkman,et al.  Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man. , 1977, Transplantation proceedings.

[7]  D. L. Klein,et al.  HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide. , 1976, Transplantation proceedings.

[8]  Clift,et al.  Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. , 1976, Blood.

[9]  S. Hellman,et al.  Limited proliferation of stem cells surviving alkylating agents , 1976, Nature.

[10]  F. Rosen,et al.  DETECTION OF GENETICALLY DETERMINED HISTOCOMPATIBILITY ANTIGEN DIFFERENCES BETWEEN HL‐A IDENTICAL AND MLC NONREACTIVE SIBLINGS , 1976, Transplantation.

[11]  J. Cassady,et al.  Modification of gastrointestinal symptoms following irradiation by low dose rate technique. , 1975, International journal of radiation oncology, biology, physics.

[12]  P. Anderson,et al.  Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. , 1975, The Journal of clinical investigation.

[13]  L. F. Fajardo,et al.  Adriamycin cardiomyopathy: enhanced cardiac damage in rabbits with combined drug and cardiac irradiation. , 1975, Radiology.

[14]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.

[15]  J. Bull,et al.  Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia. , 1974, Transplantation proceedings.

[16]  Santos Gw.  Immunosuppression for clinical marrow transplantation. , 1974 .

[17]  D. Nathan,et al.  Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. , 1974, Blood.

[18]  R. Storb,et al.  Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. , 1974, Journal of immunology.

[19]  M. Greaves,et al.  Purification of human T and B lymphocytes. , 1974, Journal of immunology.

[20]  C. L. Edwards,et al.  BONE MARROW TRANSPLANTATION IN A LEUKEMIC PATIENT FOLLOWING IMMUNOSUPPRESSION WITH ANTITHYMOCYTE GLOBULIN AND TOTAL BODY IRRADIATION , 1973, Transplantation.

[21]  J. Githens,et al.  Improved platelet function following bone marrow transplantation in an infant with the Wiskott-Aldrich syndrome. , 1973, The Journal of pediatrics.

[22]  S. Piomelli,et al.  The Haematological Effects of Glucose‐6‐Phosphate Dehydrogenase Deficiency and Thalassaemia Trait: Interaction between the Two Genes at the Phenotype Level , 1969, British journal of haematology.

[23]  R. Albertini,et al.  Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. , 1968, Lancet.

[24]  M. Cooper,et al.  Wiskott-Aldrich syndrome: An immunologic deficiency disease involving the afferent limb of immunity , 1968 .

[25]  P. Terasaki,et al.  Microdroplet Assay of Human Serum Cytotoxins , 1964, Nature.

[26]  K. Hirschhorn,et al.  Lymphocyte Interaction: A Potential Histocompatibility Test in vitro , 1964, Science.

[27]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.

[28]  P. Nowell,et al.  Chromosome preparations of leukocytes cultured from human peripheral blood. , 1960, Experimental cell research.

[29]  Aldrich Ra,et al.  Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. , 1954 .